Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Novelix Pharmaceuticals Q4 FY26 Results: Net Profit ₹0.9 Cr, Up 350.0% YoY

Novelix Pharmaceuticals Ltd reported revenue from operations of ₹25.2 Cr (+20.6% YoY) and net profit of ₹0.9 Cr (+350.0% YoY) for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations25.248.420.9
Total income25.248.420.9
Profit before exceptional items & tax1.21.30.2
Profit before tax1.21.30.2
Net profit0.91.00.2
Operating margin4.8%2.7%1.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+350.00%
Net profit, quarter on quarter-10.00%
Revenue, year on year+20.60%
Source

BSE results filing, BSE: 586565. Figures extracted from the filing.

Read the filing ↗